Literature DB >> 3934084

Release of leukotriene C4 from human eosinophils and its relation to the cell density.

T Kajita, Y Yui, H Mita, N Taniguchi, H Saito, T Mishima, T Shida.   

Abstract

Human eosinophils and neutrophils were isolated from 20 ml of peripheral blood by dextran sedimentation, centrifugation with lymphoprep, and density gradient centrifugation with Percoll. The incubation of neutrophils of purity higher than 99% (density: 1.080-1.085 g/ml) with calcium ionophore A23187 for 20 min resulted in the release of a little amount of leukotriene C4 (2.3 +/- 0.6 ng/10(6) cells) as measured with a commercial radioimmunoassay kit. On the other hand, the release from eosinophils was over 10 times that from neutrophils. When the releasability of leukotriene C4 from eosinophils was examined in relation to the cell density, the eosinophils with lower density were observed to produce greater amounts of leukotriene C4.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934084     DOI: 10.1159/000233922

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  14 in total

1.  Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.

Authors:  W F Owen; J Petersen; D M Sheff; R D Folkerth; R J Anderson; J M Corson; A L Sheffer; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

Authors:  W F Owen; J Petersen; K F Austen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

Review 4.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

5.  Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.

Authors:  T Yukawa; C Kroegel; P Evans; T Fukuda; K F Chung; P J Barnes
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

6.  A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro.

Authors:  J P Caulfield; A Hein; M E Rothenberg; W F Owen; R J Soberman; R L Stevens; K F Austen
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

7.  Release of O2- and LTC4 by murine eosinophils: role of intra- and extracellular calcium.

Authors:  B de Andres; V del Pozo; E Martin; P Palomino; C Lahoz
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

8.  Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.

Authors:  K Ochiai; I Iwamoto; H Takahashi; S Yoshida; N Nakagawa; H Tomioka; S Yoshida
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

9.  Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

Authors:  M E Rothenberg; W F Owen; D S Silberstein; J Woods; R J Soberman; K F Austen; R L Stevens
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Constitutive production of granulocyte/macrophage colony-stimulating factor by hypodense mononuclear eosinophils developed in vitro from hybrid eosinophil/basophil granulocytes.

Authors:  J A Boyce; D Friend; M F Gurish; K F Austen; W F Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.